Leadless pacemakers refer to a type of cardiac pacing device designed to provide electrical stimulation to the heart without using traditional leads (wires). These self-contained devices eliminate the need for these leads, reducing the risk of lead-related complications such as infection, breakage, and displacement.
Sizing and Forecast
The leadless pacemakers market size has grown rapidly in recent years. It will grow from $0.51 billion in 2023 to $0.58 billion in 2024 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to enhanced imaging and navigation systems, rise in focus on minimally invasive procedures, demand for improved quality of life, enhanced biocompatibility materials, and increased incidence of cardiovascular diseases.
The leadless pacemakers market size is expected to see rapid growth in the next few years. It will grow to $1.04 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to expanding clinical indications, aging population, increasing focus on patient safety and outcomes, growing emphasis on sustainability , increasing public awareness and education. Major trends in the forecast period include technological advancements and innovation, integration with wearable and digital health technologies, longer battery life and durability, patient-centric design and customization, collaboration and partnerships.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/leadless-pacemakers-global-market-report
Segmentation & Regional Insights
The leadless pacemakers market covered in this report is segmented –
1) By Type: Micra Transcatheter Pacing System, Other Types
2) By Pacing Chamber: Single Chamber, Dual Chamber
3) By Application: Hospital, Specialty Clinic, Other Applications
North America was the largest region in the leadless pacemakers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leadless pacemakers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15846&type=smp
Major Driver Impacting Market Growth
The increasing heart disease is expected to propel the growth of the leadless pacemaker market going forward. Heart diseases refer to a range of conditions that affect the heart’s structure or function, leading to impaired blood flow, abnormal heart rhythms, or other cardiovascular complications. The rising heart diseases are due to population growth and aging, lifestyle factors, stress and inactivity, healthcare system challenges, and genetic and environmental factors. Leadless pacemakers offer significant advantages in managing certain heart diseases by providing effective pacing while reducing the risk of lead-related complications and offering a less invasive implantation procedure. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, there are expected to be over 35 million new cases of cancer in 2050, a 77% increase over the projected 20 million cases in 2022. Therefore, increasing heart disease is driving the growth of the leadless pacemaker market.
Key Industry Players
Major companies operating in the leadless pacemakers market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, St. Jude Medical Inc., Lepu Medical Technology Co. Ltd., BIOTRONIK SE & Co. KG, LivaNova PLC, MicroPort Scientific Corporation, Oscor Inc., Sorin Group S.p.A. , EBR Systems Inc., Vitatron Holding B.V. , SORIN S.p.A, MEDICO S.p.A., Imricor Medical Systems Inc., Osypka Medical GmbH, Shree Pacetronix Ltd., CathRx Ltd., Cairdac
The leadless pacemakers market report table of contents includes:
1. Executive Summary
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The digital health in neurology global market report 2024from The Business Research Company provides comprehensive…
The congestive heart failure treatment devices global market report 2024from The Business Research Company provides…
The cell signaling global market report 2024from The Business Research Company provides comprehensive market statistics,…
The ai-enabled x-ray imaging solutions global market report 2024from The Business Research Company provides comprehensive…
The biomaterial wound dressing global market report 2024from The Business Research Company provides comprehensive market…
The generative ai in software development lifecycle global market report 2024from The Business Research Company…